Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$221,616
-$2,687,127 QoQ
Shares Held
612
-92.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2,786
of 3,140 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BTC Capital Management, Inc. holds $72,536,732 across 7 Drug Manufacturers - General names. AMGN ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
75,841 | $19,084,627 | |
| 2 | JNJ |
Johnson & Johnson
|
71,998 | $18,285,330 | |
| 3 | LLY |
ELI LILLY & Co
|
13,431 | $16,109,544 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
113,516 | $14,341,610 | |
| 5 | NVS |
Novartis AG
|
16,933 | $2,653,739 | |
| 6 | SNY |
Sanofi
|
43,138 | $1,840,266 | |
| 7 | AMGN |
Amgen Inc
This page
|
612 | $221,616 |
All Filings in AMGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $221,616 | 612 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $2,908,743 | 8,267 | Shares | Defined | 2026-04-20 | |
| 2025-12-31 | $2,229,634 | 6,812 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $3,106,456 | 11,008 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,244,567 | 8,039 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,078,659 | 6,672 | Shares | Defined | 2025-04-08 | |
| 2024-12-31 | $1,613,359 | 6,190 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $1,872,684 | 5,812 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,319,162 | 4,222 | Shares | Defined | 2024-07-19 | |
| No filing history on record for this holder in this stock. | ||||||